Defendant Name:
Teva Pharmaceutical Industries Limited
Defendant Type:
Public Company
Document Reference:
2016-277
Document Details
Legal Case Name
SEC v. Teva Pharmaceutical Industries Ltd.
Document Name
Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges
Document Date
22-Dec-2016
Document Format
Civil Proceeding
Case Number
16-cv-25298
Federal District Court
Florida, Southern District of Florida
Allegation Type
Foreign Corrupt Practices Act
Document Summary
On December 22, 2016, the SEC announced in a press release that Teva Pharmaceutical Industries Limited has agreed to settle parallel civil and criminal charged in relation to its violations of the FCPA. According to the SEC: "Teva failed to devise and maintain proper internal accounting controls to prevent the company's payments of bribes to win business in certain regions around the globe."
Disgorgement & Penalty Information
Resolutions
Compliance Related Independent Consultant